In re Omeprazole Patent Litigation

Claims may be nonobvious despite an argument to combine prior art elements—as with a drug formulation using enteric coatings—where the prior art does not supply an adequate reason or expectation of success for the combination.

Written by

A language model, from how the MPEP uses this case rather than from the opinion.

Confidence

medium — self-reported, not calibrated against a measured error rate

Human review

Not reviewed by a person

Read the opinion before relying on this in a filing. How these are made · Report an error